DR. NISCHALA AMMANNAGARI MD NPI 1033405154

NPI Details

DR. Nischala Ammannagari, MD is a hematology and oncology internal medicine in Albany, NY with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Nischala Ammannagari, MD NPI is 1033405154. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

400 PATROON CREEK BLVD STE 1
ALBANY, NY
ZIP 12206-014
Phone: (518) 489-0044
Fax: (518) 489-3591

The NPI 1033405154 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Vitamin d-3 level (HCPCS:82306)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Blood test, clotting time (HCPCS:85610)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Magnesium level (HCPCS:83735)
• Folic acid level, serum (HCPCS:82746)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Collection of blood sample from implanted device (HCPCS:36591)
• Ct scan of chest with contrast (HCPCS:71260)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Unclassified drugs (HCPCS:J3490)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Drawing of blood for a medical problem (HCPCS:99195)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Uric acid level, blood (HCPCS:84550)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Hepatitis c antibody measurement (HCPCS:86803)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)

The enumeration date for this NPI number is 6/27/2011 and was last updated on 9/26/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.